Deutsche Bank
IMNM icon

Deutsche Bank’s Immunome IMNM Stock Holding History

Deutsche Bank’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.36M Buy
111,593
+22,456
+25% +$481K ﹤0.01% 1807
2026
Q1 		$1.95M Buy
89,137
+12,895
+17% +$287K ﹤0.01% 1792
2025
Q4 		$1.64M Buy
76,242
+15,291
+25% +$268K ﹤0.01% 1910
2025
Q3 		$714K Buy
60,951
+7,209
+13% +$71.7K ﹤0.01% 2359
2025
Q2 		$500K Sell
53,742
-9,940
-16% -$81.5K ﹤0.01% 2460
2025
Q1 		$429K Buy
63,682
+17,607
+38% +$169K ﹤0.01% 2563
2024
Q4 		$489K Buy
46,075
+15,514
+51% +$187K ﹤0.01% 2623
2024
Q3 		$447K Buy
30,561
+8,535
+39% +$121K ﹤0.01% 2520
2024
Q2 		$267K Buy
22,026
+21,574
+4,773% +$337K ﹤0.01% 2660
2024
Q1 		$11.2K Buy
+452
New +$9.17K ﹤0.01% 3528
2021
Q2 		– Sell
-1,340
Closed -$45K – 4692
2021
Q1 		$45K Sell
1,340
-126
-9% -$3.13K ﹤0.01% 4259
2020
Q4 		$14K Buy
+1,466
New +$17.1K ﹤0.01% 4277

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Deutsche Bank's IMNM Position: Q2 2026 in Review

Deutsche Bank increased its Immunome (IMNM) stake by 25% in Q2 2026, buying an estimated $481K and bringing the position to 111,593 shares worth $2.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1807.

Deutsche Bank first reported a position in IMNM in Q4 2020 and has held it in 12 quarters since. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Deutsche Bank held 111,593 shares of Immunome worth $2.36M as of Q2 2026.
  • Deutsche Bank bought 22,456 Immunome shares in Q2 2026, an estimated $481K.
  • Immunome made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1807 holding.
  • Deutsche Bank first reported a position in Immunome in Q4 2020 and has held it in 12 quarters since.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.